BC Children’s Hospital investigator Dr. Kyla Hildebrand not only conducts research in the area of allergy and clinical immunology, but this clinical assistant professor in the Department of Pediatrics in the Faculty of Medicine at the University of British Columbia is also well known for her leadership in undergraduate and postgraduate medical education.
Healthy Starts | Lab, Project & Program Websites
Canadian Burkholderia cepacia complex Research and Referral Repository
We can provide species identification for members of the Burkholderia cepacia complex of bacteria. We also can provide strain typing information, as well as identifications for other species which grow on Burkholderia cepacia selective agar and for which the preliminary identification might be equivocal: such as B. gladioli, Ralstonia species, Pandoraea species and others. Most of our work is for cystic fibrosis clinics, however we are very happy to provide assistance to anyone else requiring identification of these bacteria.
Kobor Lab
We employ various approaches to determine how DNA methylation and chromatin protein modifications are regulated, how they interact with the underlying genetic sequence to affect which genes are expressed in which cells, and how changes to these epigenetic marks can affect human development and lifelong health trajectories. Together, the research in our lab bridges the molecular mechanisms of epigenetic regulation and the social and environmental determinants of human health to develop a comprehensive understanding of early life.
Kollmann Lab
We are systematically dissecting the molecular mechanisms of the neonatal and infant response to infection or vaccination. Based on that knowledge, we are identifying immune modulators that help protect newborns and infants.
Lavoie Lab
The Lavoie Lab studies the development of the human immune system and its impacts on the health of babies. Dr. Pascal Lavoie is a neonatologist with dual training in medicine and research (MD/PhD).
Nutrition & Metabolism Research
Nutrition and metabolism research at BC Children's spans the full spectrum from explanation of biological action, to pre-clinical and clinical studies, to population health.
The OPSiP Study
The OPSiP study (short for "Oral Probiotic Supplementation in Pregnancy to Reduce Group B Streptococcus Colonization") is a randomized controlled trial (RCT) that is recruiting 450 participants in Vancouver, British Columbia.
Pediatric Sepsis Data CoLab
The Pediatric Sepsis Data CoLaboratory (Sepsis CoLab) is a new international data-sharing network for collaboration to address pediatric sepsis mortality and morbidity.
Pocket Doc for Pneumonia
Pocket Doc for Pneumonia is a low-cost smartphone tool that uses a light-weight sensor and a data-driven app to assess a child’s vital signs and overall condition, deliver an accurate diagnosis and recommend inexpensive, life-saving treatments such as antibiotics, oxygen and fluids.
Smart Discharges
The Center for International Child Health has developed Smart Discharges to help children stay healthy after they leave the hospital to return home following a severe infection.
Turvey Lab
The Turvey Lab uses precision health to determine the cellular, molecular and genetic abnormalities responsible for immunological disease.
The Vaccine Evaluation Center
The Vaccine Evaluation Center (VEC) is an academic center of excellence involved in vaccine and immunization research.
Get Involved
We need you today for a better tomorrow. Our kids are counting on it.
Recent News See all
Dr. Srinivas Murthy named research chair in pandemic preparedness
Dr. Srinivas Murthy has been awarded the Health Research Foundation of Innovative Medicines Canada Chair in Pandemic Preparedness Research.
Summer Safety
With summer in full swing, more British Columbians are heading to rivers, lakes and the ocean to cool down and relax. While water activities can be fun, they can come with a risk of drowning for those who aren't prepared.
Congratulations to the recipients of the 2020 BCCHR Studentships and Fellowships!
Congratulations to the recipients of the 2020 BCCHR Studentships and Fellowships!
Omega-3s provide no benefits against bronchopulmonary dysplasia in very preterm infants
Consumption of DHA supplements, an omega-3 fatty acid, by breastfeeding mothers is ineffective in preventing bronchopulmonary dysplasia in preterm infants born before the 29th week of pregnancy. This is the main conclusion of a Canada-wide study published today in the Journal of the American Medical Association (JAMA).
Donate to Research
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.